This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Wellcome Inc.. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: Nariman Bomanshaw Mehta: Innovator in Mental Health Treatments
Introduction
Nariman Bomanshaw Mehta is a notable inventor based in Lady Lake, FL (US). He has made significant contributions to the field of human medicine, particularly in the treatment of mental disorders. With a total of 2 patents, Mehta's work focuses on innovative compounds that aim to improve mental health outcomes.
Latest Patents
Mehta's latest patents include the "Arylmorpholine preparation and use" and "Novel morpholines of formula (I) and their salts." These compounds, where R and R1 can be either hydrogen or fluorine and R2 can be hydrogen or methyl, have various applications in treating mental disorders such as depression. The methods described in his patents involve administering an antidepressant effective amount of these compounds or their pharmaceutically acceptable salts to individuals suffering from depression.
Career Highlights
Throughout his career, Nariman Mehta has been associated with Glaxo Wellcome Inc., a company known for its commitment to advancing healthcare through innovative solutions. His work has contributed to the development of new therapeutic options for patients dealing with mental health issues.
Collaborations
Mehta has collaborated with notable colleagues, including Grady Evan Boswell and James L. Kelley, to further enhance the research and development of his patented compounds. These collaborations have played a crucial role in advancing the understanding and application of his inventions.
Conclusion
Nariman Bomanshaw Mehta's contributions to the field of mental health through his innovative patents highlight the importance of research in developing effective treatments for depression. His work continues to inspire advancements in medical science and improve the lives of many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
